13 February 2018
By Dr Wendy Winnall - PCFA Research Team
Exciting news has been reported at this year’s ASCO Genitourinary Cancers Symposium. Results were reported from two key clinical trials assessing new treatments for men with non-metastatic castration resistant prostate cancer – a stage for which there are currently no approved treatments. Both trials were very successful and the results should lead to two options for prostate cancer patients who currently have none.
To read the full article just log into the PCFA Online Community.
If you're not already a member, it is free and easy to join.
